FDA Orange Book
Generic for Depacon
Depacon contains valproate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Depacon is valproate. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP.
Run it in Rivvi
Map Depacon and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Depacon products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, injection | EQ 100MG BASE/ML | Discontinued | None | 3 | AP |
NDA 020593, held by ABBVIE INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic valproate
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| SAGENT PHARMACEUTICALS | 076295 | AP (A-rated, therapeutically equivalent) | November 14, 2002 | EQ 100MG BASE/ML |
| FRESENIUS KABI USA LLC | 076539 | AP (A-rated, therapeutically equivalent) | June 26, 2003 | EQ 100MG BASE/ML |
| HIKMA FARMACEUTICA (PORTUGAL) SA | 078523 | AP (A-rated, therapeutically equivalent) | February 17, 2010 | EQ 100MG BASE/ML |
Questions
Is there a generic for Depacon?
Yes. The generic name for Depacon is valproate. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP.
What is the generic name for Depacon?
The active ingredient in Depacon is valproate, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.